Rafoxanide

DB19672ExperimentalSmall molecule

Rafoxanide is a small molecule drug. Rafoxanide has a monoisotopic molecular weight of 624.82 Da.

Mechanism: Pharmacologically active on Cyclin-dependent kinase 6, Cyclin-dependent kinase 4, and Non-selective voltage-gated ion channel VDAC1
Curator reviewed
Formula / weight: C₁₉H₁₁Cl₂I₂NO₃ · 626.01 g/mol (avg)
Code names: NSC-355278

Resolves to

Compound

Structure

InChIKeyNEMNPWINWMHUMR-UHFFFAOYSA-NSMILESOC1=C(C=C(I)C=C1I)C(=O)NC1=CC(Cl)=C(OC2=CC=C(Cl)C=C2)C=C1

Targets

What you can answer from here — as of September 23, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Rafoxanide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.